Avigen Presents At the 37th Annual Meeting of the Society for Neuroscience
November 04, 2007 15:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Nov. 4, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapies for the treatment of chronic neurological conditions, today announced the...
Avigen's AV411 Shows Promising Initial Results for Neuropathic Pain
November 03, 2007 15:30 ET
|
Avigen, Inc.
SALT LAKE CITY, Nov. 3, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today announced first-in-patient top line data...
Avigen to Present At Upcoming Healthcare Conferences
October 30, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Oct. 30, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapies for the treatment of chronic neurological conditions, announced today...
Avigen Reports Third Quarter 2007 Financial Results
October 24, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Oct. 24, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapies for the treatment of chronic neurological conditions, today reported...
Avigen to Present At 2007 BIO Investor Forum
October 03, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Oct. 3, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for chronic neurological care, announced today that Chief Business...
Avigen to Present At UBS Global Life Sciences Conference
September 18, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Sept. 18, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for chronic neurological care, announced today that President and CEO...
Avigen Initiates European Multi-Center AV650 Phase II Spasticity Trial in Patients with Multiple Sclerosis
September 05, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Sept. 5, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for the treatment of neurological conditions, today announced the...
Avigen Initiates U.S. Clinical Development for AV411
August 13, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Aug. 13, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions, today...
Avigen Reports Second Quarter 2007 Financial Results
July 25, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., July 25, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions, today...
Expert Opinion Highlights Avigen's AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal
June 26, 2007 12:58 ET
|
Avigen, Inc.
ALAMEDA, Calif., June 26, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for the treatment of neurological conditions, announced today that...